FIELD: biotechnology.
SUBSTANCE: following is disclosed: the use of an antibody or antibody fragment specific for CD38 in the prevention or treatment of an autoimmune disease mediated by autoantibodies.
EFFECT: invention is effective in the treatment of membranous nephropathy.
14 cl, 12 dwg, 5 tbl, 6 ex
| Title |
Year |
Author |
Number |
| TACI-Fc FUSION PROTEIN AND ITS USE |
2019 |
- Fang, Jianmin
- Wang, Wenxiang
- Li, Lin
|
RU2814988C2 |
| SUBCUTANEOUS INJECTION OF ANTI-CD38 ANTIBODIES |
2019 |
- Dal, Martin
- Fedik, Erik
- Evans, Robert
- Chzhao, Lin
|
RU2782950C2 |
| SUBCUTANEOUS DOSING OF ANTI-CD38 ANTIBODIES |
2019 |
- Fedyk, Eric
- Hanley, Michael
- Palumbo, Antonio
|
RU2810953C2 |
| ANTIBODIES TO LIGAND OF RECEPTOR TYROSINE KINASE 3 SIMILAR TO PRODUCT OF PROTOONCOGENE OF FELINE SARCOMA VIRUS (FMS) OF MCDONOUGH (FLT3L) STRAIN AND OPTIONS OF THEIR USE FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |
2019 |
- Hansen, Anna
- Xiao, Xiaodong
- Pavlik, Peter
- Chen, Yan
- Ettinger, Rachel
|
RU2788128C2 |
| METHODS AND MATERIALS FOR ASSESSMENT OF RESPONSE TO THERAPY AGAINST PLASMA-BLASTS AND PLASMA CELLS |
2017 |
- Smithson, Glennda
- Estevam, Jose
- Jones, Nicholas
|
RU2787629C2 |
| COMBINATION CANCER THERAPIES TARGETTING CD38 AND TGF-BETA |
2019 |
- Adrian, Francisco
- Gregory, Richard C.
- Shapiro, Gary
- Van De Velde, Helgi
|
RU2808632C2 |
| IMMUNE CELLS EXPRESSING INVERSE UNIVERSAL CHIMERIC ANTIGEN RECEPTOR, FOR TARGETING VARIOUS MULTIPLE ANTIGENS AND METHOD FOR PRODUCTION AND USE THEREOF FOR TREATING CANCER, INFECTIONS AND AUTOIMMUNE DISEASES |
2019 |
|
RU2824391C2 |
| AGENT FOR TREATING MULTIPLE MYELOMA (MM) |
2016 |
- Leclair StÉphane
- Endell Jan
- HÄrtle Stefan
|
RU2723047C2 |
| ANTIBODIES TO CD40 FOR USE IN THE TREATMENT OF SJOGREN'S SYNDROME |
2018 |
- Espie, Pascal
- Gergely, Peter
- Rush, James
|
RU2790558C2 |
| DOUBLE SPECIFICITY ANTIBODIES |
2014 |
- Fuh Germaine
- Lee Chingwei V.
- Koenig Patrick
|
RU2732032C2 |
